Area 2: Clinical Epidemiology and Public Health
The area on cardiovascular and renal diseases is formed by three research groups, two competing groups and a partner.
The area has two main objectives: first, to improve the knowledge on the prevention of the development of cardiovascular calcifications in the population, already affecting 50 percent of people between 40 and 49 years and 80 per cent of people over 69 years. Second, with respect to patients with kidney failure, to continue working on the study of renal stones in three key strands: aetiology, diagnosis and treatment.
These objectives can be broken down into more specific objectives, among others, the following:
- Improving the diagnosis of kidney stones, using internet technology.
- Introduction of new treatments for hypercalciuria, to avoid most of the side effects and with a more convenient and economical dosage.
- Development, of a new product, a mouthwash, for the prevention of dental plaque.
- Continue with the development of functional foods rich in phytate that can help to reduce the risk of kidney stones.
- Improve knowledge on the prevention of the development of calcifications in soft tissue.
- Deepen the understanding of the beneficial effects of the Mediterranean diet on cardiovascular morbidity and mortality.
- Further research on the effect of phytate in the prevention of cardiovascular calcifications.
- Establish the variability between hospitals in the quantification of the mitral insufficiency.
- Improve the diagnosis of myocardial viability in the context of ischemic heart disease.
- Energetic metabolism and nutrition
- Cancer cell biology
- Human genetics
- Translational oncology multidisciplinary group
- Clinical and translational research
- Interactions between metalic ions and molecules of medical interest
- Research on renal lithiasis and biomineralization
- Chemical reactivity and drug design
- Antibiotic resistance and pathogenesis of bacterial infections
- Cell Therapy and Tissue Engineering (TERCIT)